TWD
NAUT icon

True Wealth Design’s Nautilus Biotechnolgy NAUT Stock Holding History

True Wealth Design’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-17
Closed -$15 – 2734
2025
Q3 		$15 Sell
17
-130
-88% -$96 ﹤0.01% 2674
2025
Q2 		$107 Buy
147
+135
+1,125% +$101 ﹤0.01% 2224
2025
Q1 		$11 Buy
+12
New +$18 ﹤0.01% 2629

Other funds holding NAUT

ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return
MVG
Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
ACI
Amazon.com Inc Seattle, Washington $4.42B AUM 22.6% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
ST
Sentinel Trust Houston, Texas $1.13B AUM 24.31% 1-Year Est. Return

True Wealth Design's NAUT Position: Q4 2025 in Review

True Wealth Design sold out of Nautilus Biotechnolgy (NAUT) in Q4 2025, closing a stake of 17 shares — an estimated $15 sold.

True Wealth Design first reported a position in NAUT in Q1 2025 and held it in 3 quarters. The position peaked at $107 in Q2 2025. 68 funds tracked by Wall St. Rank hold NAUT as of Q4 2025.

  • True Wealth Design reported no remaining Nautilus Biotechnolgy position as of Q4 2025 after selling out during the quarter.
  • True Wealth Design sold 17 Nautilus Biotechnolgy shares in Q4 2025, an estimated $15.
  • True Wealth Design first reported a position in Nautilus Biotechnolgy in Q1 2025 and held it in 3 quarters.
  • True Wealth Design's Nautilus Biotechnolgy position peaked at $107 in Q2 2025.
  • 68 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q4 2025.

Based on True Wealth Design's 13F filing for Q4 2025, filed 8 Jan 2026.